Zyla Life Sciences Investing Cash Flow
Zyla Life Sciences reported Investing Cash Flow of -$3.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2020-05-14
- Zyla Life Sciences net cash provided by (used in) investing activities for the quarter ending 2020-03-31 was -$3.00K.
- Zyla Life Sciences net cash provided by (used in) investing activities for the quarter ending 2018-12-31 was $11.01M, a 149.90% increase year-over-year.
- Zyla Life Sciences net cash provided by (used in) investing activities for the quarter ending 2018-09-30 was $16.26M.
- Zyla Life Sciences net cash provided by (used in) investing activities for the quarter ending 2018-06-30 was $8.71M, a 57.82% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) investing activities for fiscal 2018 was $55.21M.
- Zyla Life Sciences net cash provided by (used in) investing activities for fiscal 2017 was -$17.58M, a 135.98% decline from fiscal 2016.
- Zyla Life Sciences net cash provided by (used in) investing activities for fiscal 2016 was $48.87M.
- Zyla Life Sciences net cash provided by (used in) investing activities for fiscal 2015 was -$119.79M.
| Period end | Net Cash Provided by (Used in) Investing Activities 2 month | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 5 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 8 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 11 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$3.00K 10-Q · filed 2020-05-14 | ||||||||||
| 2019-12-31 | $4.97M 10-K · filed 2020-03-26 | ||||||||||
| 2019-09-30 | $4.97M 10-Q · filed 2019-11-14 | ||||||||||
| 2019-06-30 | $4.97M 10-Q · filed 2019-08-13 | ||||||||||
| 2019-03-31 | $4.99M 10-Q · filed 2020-05-14 | ||||||||||
| 2018-12-31 | $11.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $27.27M derived: sum of 2 quarters · filed 2020-03-26 | $35.98M derived: sum of 3 quarters · filed 2020-03-26 | $55.21M 10-K · filed 2020-03-26 | |||||||
| 2018-09-30 | $16.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $24.97M derived: sum of 2 quarters · filed 2019-11-14 | $44.20M 10-Q · filed 2019-11-14 | $48.61M derived: sum of 4 quarters · filed 2019-11-14 | |||||||
| 2018-06-30 | $8.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $27.94M 10-Q · filed 2018-08-09 | $32.34M derived: sum of 3 quarters · filed 2019-03-29 | $25.72M derived: sum of 4 quarters · filed 2019-03-29 | |||||||
| 2018-03-31 | $19.23M 10-Q · filed 2018-05-10 | $23.64M derived: sum of 2 quarters · filed 2019-03-29 | $17.01M derived: sum of 3 quarters · filed 2019-03-29 | $37.66M derived: sum of 4 quarters · filed 2019-03-29 | |||||||
| 2017-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$2.22M derived: sum of 2 quarters · filed 2019-03-29 | $18.43M derived: sum of 3 quarters · filed 2019-03-29 | -$17.58M 10-K · filed 2019-03-29 | -$17.98M 10-K · filed 2018-03-16 | ||||||
| 2017-09-30 | -$6.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $14.02M derived: sum of 2 quarters · filed 2018-11-19 | -$21.99M 10-Q · filed 2018-11-19 | -$22.39M 10-Q · filed 2017-11-08 | -$8.10M derived: sum of 4 quarters · filed 2018-11-19 | ||||||
| 2017-06-30 | $20.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$15.37M 10-Q · filed 2018-08-09 | -$15.77M 10-Q · filed 2017-08-09 | -$1.48M derived: sum of 3 quarters · filed 2018-08-09 | $9.65M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2017-03-31 | -$36.01M 10-Q · filed 2018-05-10 | -$22.12M derived: sum of 2 quarters · filed 2018-05-10 | -$10.99M derived: sum of 3 quarters · filed 2018-05-10 | ||||||||
| 2016-12-31 | $13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $25.02M derived: sum of 2 quarters · filed 2018-03-16 | $48.87M 10-K · filed 2018-03-16 | ||||||||
| 2016-09-30 | $11.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $34.98M 10-Q · filed 2017-11-08 | |||||||||
| 2016-06-30 | $23.85M 10-Q · filed 2017-08-09 | ||||||||||
| 2015-12-31 | -$119.79M 10-K · filed 2018-03-16 |